Navigation Links
Preference for alcohol in adolescence may lead to heavy drinking
Date:5/5/2008

DURHAM, N.C. Scientists at Duke University Medical Center have shown a connection between early drinking patterns and a tendency to be a heavy drinker in adulthood, in a study of adolescent rats.

Drinking patterns in adolescents may be set after only a few exposures to alcohol, said Nicole L. Schramm-Sapyta, research associate in the Department of Pharmacology and Cancer Biology at Duke University School of Medicine. Rats that demonstrated a taste for alcohol after only three nights of drinking were very likely to be the biggest drinkers after longer-term exposure.

During the first three nights of the study, the rats were given only alcohol to consume. After that, for 10 days, they had a choice of water or alcohol. Their drinking was measured right after they had traveled through an elevated maze, a way to raise anxiety levels and measure stress-related hormone levels. They also were tested for drinking after scientists observed their preference for new objects and for exploring a new place.

We decided to examine stress and novelty seeking because these are two characteristics we see among people who develop problem drinking, said Schramm-Sapyta, first author of the study published in the May issue of Alcoholism: Clinical and Experimental Research. The study was funded by grants from the National Institute on Drug Abuse.

The scientists found that the rats that drank the most on the third day of the study also consumed the most alcohol in the later days of the study. The rodents sobered up for two days without any alcohol and again were given a choice. When the alcohol was returned, those that drank heavily at the beginning of the experiment returned to their habit.

However, the scientists learned that stress and novelty seeking were not related to drinking outcomes. This suggests that there are other traits that scientists should be looking for, that are related to the early experiences of drinking, said Schramm-
'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Study Indicates Strong Consumer Preference to Fix Medicare Part D and Medicaid Flaws Threatening Access to Prescription Drugs
2. Surgeons Preferences Dictate Choice of Kidney Cancer Surgery
3. Surgeons Preferences Dictate Choice of Kidney Cancer Surgery
4. U.S. Health Officials Back Off Preference for New MMRV Vaccine
5. High alcohol consumption increases stroke risk among Chinese men
6. High alcohol consumption increases stroke risk, Tulane study says
7. Alcoholics With Cirrhosis Have More Brain Damage
8. Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids
9. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
10. Frequent alcohol consumption increases cancer risk in older women
11. Family history of alcoholism affects response to drug used to treat heavy drinking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...effective against Lennox-Gastaut syndrome , ...ug called Banzel (rufinamide) has been approved as...ilepsy called Lennox-Gastaut syndrome, the U.S. Fo...The approval was based on results of a four-month .... Compared to patients who took a placebo, those w...
(Date:11/21/2008)...PRNewswire-USNewswire/ -- New research at West Vi...s, spitless tobacco product aimed at young adults ...t RJ Reynolds, Camel Snus - touted as a socially a...risingly high levels of nicotine. , , "Came...f products," said Bruce Adkins of the state Divisi...
(Date:11/21/2008)...ewswire-USNewswire/ -- U.S. News & World Repor... (NCQA) ranked BlueChoice(R) HealthPlan of South C...Plans(TM), published in U.S. News & World Repo...ual ranking ranks the nation,s best health plans b...NCQA accreditation scores. NCQA and U.S. News &...
(Date:11/21/2008)...ewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (...s overwhelmingly approved the proposals submitted ...a Pharmaceuticals Industries Ltd. (Nasdaq: TEVA ...whelming support of the transaction by the Barr sh... and CEO. "We are pleased with the progress that w...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...rganization (NACO) of India plans to promote the d...attle against HIV/AIDS//. The third phase of the N...y to be launched in April. Statistics show that ...the private sector for outpatient care and over 50...
...fusal of surgery to known smokers is all set to be...ating the issue in this week’s BMJ//. The issue wa...t last year to remove smokers from the waiting lis...Peters who is from Concord Repatriation General Ho...
...on therapy on the exterior along with radiation se...highly effective// for treatment of prostate cance...of Radiation Oncology Biology Physics has revealed...undergone such a combination therapy have been com...
...or Disease Control and Prevention (CDC) Atlanta's ...is time the US changed its guidelines// and made T...irrespective of how long they have been residing t...ated if all foreign-born residents from high-risk ...
Other Medicine News:Health News:Refusal of Surgery for Smokers – To Be or Not to Be 2Health News:All Foreign-born Nationals In US To Be Tested For TB 2
(Date:11/21/2008)...England, November 21 , ...an Committee for Medicinal Products for Human Use ...n for the approval of Enbrel(R),(etanercept) as a...,adolescents with severe plaque psoriasis. If appr...mmittee,s recommendation, Enbrel will become the,...
(Date:11/20/2008)... , , PHILADELPHIA, Nov. 20 /PRNewswire-Firs...unced that the United States Food and Drug Adminis...MACTA(R) (eltrombopag) for the treatment of thromb...thic) thrombocytopenic purpura (ITP) who have had ...oglobulins or splenectomy. The approval is a signi...
(Date:11/20/2008)...lif., Nov. 20 Duska Ther...nced today that it has submitted its,pivotal Phas...r a Special,Protocol Assessment (SPA) procedure w..., Subject to securing an agreement with the...tive, double-blind, placebo-controlled and randomi...
(Date:11/19/2008)...O, Nov. 19 Posit Science Corporati...the Society for Neuroscience,Annual Conference in...e,training may benefit Baby Boomers. The compute...m (TM) uses adaptive exercises that target auditor...ed to drive generalized,improvements in cognition...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pregnant mice block out unwelcome admirers to protect their pups 4122 1Pregnant mice block out unwelcome admirers to protect their pups 4122 2Capella University Launches Online PhD Specialization in Nursing Education 24214 1Capella University Launches Online PhD Specialization in Nursing Education 24214 2Capella University Launches Online PhD Specialization in Nursing Education 24214 3Incidence of Mantle Cell Lymphoma on Rise 24211 1Incidence of Mantle Cell Lymphoma on Rise 24211 2Breast Fed Babies Have Fewer GI Infections 24208 1Breast Fed Babies Have Fewer GI Infections 24208 2
...roach to Address Growing Problem of Antibiotic Res...ER, British Columbia, March 26, 2007 /PRNewswire/ ... IDR-1 is the first,immune system trigger to cure ...ccording to a paper published in the April 2007,is...ghlights the work of Inimex and its,co-founders Dr...
...rial Shows CRESTOR Slowed Progression Of Atheroscl...sease , LONDON, March 26, 2006-AstraZeneca today a... is the first study to show a,positive effect on a...id artery disease and at low risk of coronary hear...uvastatin) 40mg and presented at,56th Scientific S...
Other Medicine Technology:Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 2First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 3First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 4First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 5
Grafton DBM Matrix PLF is the first bone graft material designed specifically for posterolateral fusion procedures. Unique trough-like design allows for easy use with allograft/autograft bone. Demine
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%.
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%.
Inductive demineralized bone matrix and conductive cancellous chips. DBM and cancellous chips will be free of foreign matter. Demineralized bone matrix particle size is 125 to 1000 . Cancellous chip
Medicine Products: